A Case of Nivolumab-induced Hypophysitis in a 72-year-old Female with Metastatic Melanoma

Authors

DOI:

https://doi.org/10.46570/utjms.vol11-2023-898

Keywords:

Hypophysitis, hematology/oncology, melanoma, metastatic cancer, Complications of Immunotherapy

References

Gubbi S, Hannah-Shmouni F, Verbalis JG, Koch CA. Hypophysitis: An update on the novel forms, diagnosis and management of disorders of pituitary inflammation. Best Practice & Research Clinical Endocrinology & Metabolism. 2019;33(6):101371. doi:10.1016/j.beem.2019.101371 https://pubmed.ncbi.nlm.nih.gov/31866206/

Imga NN, Yildirim AE, Baser OO, Berker D. Clinical and hormonal characteristics of patients with different types of hypophysitis: A single-center experience. Archives of Endocrinology and Metabolism. 2019;63(1):47-52. doi:10.20945/2359-3997000000102 https://pubmed.ncbi.nlm.nih.gov/30864631/

Downloads

Published

2023-12-15

How to Cite

Pallerla, MS, V., Persaud, MS, A., & Vijendra, D. (2023). A Case of Nivolumab-induced Hypophysitis in a 72-year-old Female with Metastatic Melanoma. Translation: The University of Toledo Journal of Medical Sciences, 11(3). https://doi.org/10.46570/utjms.vol11-2023-898

Issue

Section

Dr. Lance D. Dworkin Department of Medicine Research Symposium